Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 21;25(1):153.
doi: 10.1186/s13054-021-03571-z.

Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?

Paul-Henri Wicky  1 , Michael S Niedermann  2   3 , Jean-François Timsit  4   5
Affiliations
Editorial

Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?

Paul-Henri Wicky et al. Crit Care. .

Abstract

We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2 infection and with other ARDS. The differences in epidemiology and outcome will be detailed. Possible explanations of differences in pathophysiology of VAP in Sarscov2 infections will be cited and discussed.

Keywords: ARDS; COVID-19; Prognostic; Superinfections; Ventilation-associated pneumonia.

PubMed Disclaimer

Conflict of interest statement

JFT declares advisory board participation for Pfizer, Merck, Bayer pharma, Shionoghi, Medimune, Paratek, Gilead, Beckton-Dickinson, lecture fees from Merck, Biomerieux, Pfizer and Grants to his research group from Pfizer, Merck, Thermofisher all outside the submitted work. The other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
VAP risk in Sars-Cov2 infections and other ARDS: similarities and differences. The main elements of pathophysiology, diagnosis and treatment of VAP in ARDS patients are schematized in blue. In red, the potential elements due to sars-cov2 are discussed. MDR Multi-drug resistant; PDR pan-drug resistant; PK pharmacokinetic; mPCR multiplex PCR or other molecular methods
See this image and copyright information in PMC

References

    1. Blonz G, Kouatchet A, Chudeau N, Pontis E, Lorber J, Lemeur A, et al. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care. 2021;25:6–12. doi: 10.1186/s13054-021-03493-w. - DOI - PMC - PubMed
    1. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi: 10.1016/j.cmi.2020.07.041. - DOI - PMC - PubMed
    1. Razazi K, Arrestier R, Haudebourg AF, Benelli B, Carteaux G, Decousser J-W, et al. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease. Crit Care. 2020;24(1):699. doi: 10.1186/s13054-020-03417-0. - DOI - PMC - PubMed
    1. Luyt C-E, Sahnoun T, Gautier M, Vidal P, Burrel S, de Chambrun MP, et al. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020;10(1):158. doi: 10.1186/s13613-020-00775-4. - DOI - PMC - PubMed
    1. Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021;25(1):25. doi: 10.1186/s13054-021-03460-5. - DOI - PMC - PubMed

Publication types